title: Antiretroviral therapy: when to start.
abstract: In this article, the scientific evidence and professional guidelines regarding the timing of antiretroviral therapy initiation are reviewed, with discussion of the increasingly persuasive evidence in favor of starting treatment early in the course of human immunodeficiency virus disease.
authors.affiliation: Division of Infectious Diseases, School of Medicine, University of North Carolina, 130 Mason Farm Road, CB# 7030, Chapel Hill, NC 27599-7030, USA.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Sellers
authors.affiliation: Division of Infectious Diseases, School of Medicine, University of North Carolina, 130 Mason Farm Road, CB# 7030, Chapel Hill, NC 27599-7030, USA. Electronic address: david_wohl@med.unc.edu.
authors.forename: David A
authors.initials: DA
authors.lastname: Wohl
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D017410:Practice Guidelines as Topic; D013997:Time Factors
chemical_list: D044966:Anti-Retroviral Agents
keywords: Antiretroviral; CD4; Human immunodeficiency virus; Initiation; Start; Therapy; Timing